Nevertheless, the presence of inhibitory factors within the tumor microenvironment, such as transforming growth factor-β (TGF-β) produced by tumor cells, can significantly diminish NK cell functionality and weaken their anti-tumor responses (39, 40). The gene discussed is TGFB1; the disease is neoplasm.